Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo

Journal of Surgical Research

Volumn 183, Issue 2, 2013, Pages 509-516

  Wang, Jichun ^a   Yang, Hongxin ^a   Hu, Xiaorong ^a   Fu, Wenwen ^a   Xie, Jing ^a   Zhou, Xiaoya ^a   Xu, Weipan ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Dobutamine; Heme oxygenase 1; High mobility group box 1 protein; Myocardial ischemia and reperfusion

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA 1 ADRENERGIC RECEPTOR; CREATINE KINASE; DOBUTAMINE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTOPORPHYRIN ZINC; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; HEART INFARCTION SIZE; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

DOBUTAMINE; HEME OXYGENASE-1; HIGH MOBILITY GROUP BOX 1 PROTEIN; MYOCARDIAL ISCHEMIA AND REPERFUSION;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; CHROMONES; DISEASE MODELS, ANIMAL; DOBUTAMINE; ENZYME INHIBITORS; HEART; HEME OXYGENASE-1; HMGB1 PROTEIN; IMIDAZOLES; MALE; MORPHOLINES; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTOPORPHYRINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880262293     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.02.051     Document Type: Article

References (30)

1. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31
2. P.R. Hansen Myocardial reperfusion injury: experimental evidence and clinical relevance Eur Heart J 16 1995 734
3. A.P. Vakeva, A. Agah, S.A. Rollins, L.A. Matis, L. Li, and G.L. Stahl Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy Circulation 97 1998 2259
4. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216
5. X. Hu, H. Jiang, and Q. Bai Increased serum HMGB1 is related to the severity of coronary artery stenosis Clin Chim Acta 406 2009 139
6. X. Hu, W. Fu, and H. Jiang HMGB1: a potential therapeutic target for myocardial ischemia and reperfusion injury Int J Cardiol 155 2012 489
7. L.E. Otterbein, M.P. Soares, K. Yamashita, and F.H. Bach Heme oxygenase-1: unleashing the protective properties of heme Trends Immunol 24 2003 449
8. J.S. Hwa, Y.C. Jin, and Y.S. Lee 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction J Ethnopharmacol 139 2012 605
9. Y.M. Ha, S.A. Ham, and Y.M. Kim beta(1)-Adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice Biochem Pharmacol 82 2011 769
10. R. Salie, J.A. Moolman, and A. Lochner The role of beta-adrenergic receptors in the cardioprotective effects of beta-preconditioning (betaPC) Cardiovasc Drugs Ther 25 2011 31
11. C. Pantos, I. Mourouzis, and S. Tzeis Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment Eur J Pharmacol 460 2003 155
12. G.K. Asimakis, and V.R. Conti Preconditioning with dobutamine in the isolated rat heart Life Sci 57 1995 177
13. E.R. Gross, A.K. Hsu, and G.J. Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 2004 960
14. N.C. Weber, O. Toma, and J.I. Wolter The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK Br J Pharmacol 144 2005 123
15. Y.C. Jin, C.W. Kim, and Y.M. Kim Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo Eur J Pharmacol 614 2009 91
16. L. Yan, Q. Tang, and D. Shen SOCS-1 inhibits TNF-alpha-induced cardiomyocyte apoptosis via ERK1/2 pathway activation Inflammation 31 2008 180
17. J. Yang, H. Jiang, and J. Yang Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway Mol Cell Biochem 330 2009 39
18. X. Hu, X. Zhou, and B. He Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats Eur J Pharmacol 638 2010 84
19. R. Takamiya, C.C. Hung, and S.R. Hall High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient mice Am J Respir Cell Mol Biol 41 2009 129
20. K. Tsoyi, T.Y. Lee, and Y.S. Lee Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo Mol Pharmacol 76 2009 173
21. A. Paine, B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential Biochem Pharmacol 80 2010 1895
22. M.K. Park, Y.J. Kang, and Y.M. Ha EP2 receptor activation by prostaglandin E2 leads to induction of HO-1 via PKA and PI3K pathways in C6 cells Biochem Biophys Res Commun 379 2009 1043
23. M.D. Maines The heme oxygenase system: a regulator of second messenger gases Annu Rev Pharmacol Toxicol 37 1997 517
24. C.J. Vlahos, W.F. Matter, K.Y. Hui, and R.F. Brown A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002) J Biol Chem 269 1994 5241
25. J. Saklatvala, L. Rawlinson, and R.J. Waller Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue J Biol Chem 271 1996 6586
26. H. Wang, H. Liao, and M. Ochani Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat Med 10 2004 1216
27. H.W. Eom, S.Y. Park, and Y.H. Kim Bambusae Caulis in Taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1- and Nrf-2-mediated pathways Int J Mol Med 30 2012 1512
28. G.H. Jin, S.Y. Park, and E. Kim Anti-inflammatory activity of Bambusae Caulis in Taeniam through heme oxygenase-1 expression via Nrf-2 and p38 MAPK signaling in macrophages Environ Toxicol Pharmacol 34 2012 315
29. K.J. Senthil Kumar, J.W. Liao, J.H. Xiao, M. Gokila Vani, and S.Y. Wang Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes Toxicol In Vitro 26 2012 700
30. E.Y. Ryu, A.J. Park, and S.Y. Park Inhibitory effects of Ginkgo biloba extract on inflammatory mediator production by Porphyromonas gingivalis lipopolysaccharide in murine macrophages via Nrf-2 mediated heme oxygenase-1 signaling pathways Inflammation 35 2012 1477